Vertex Pharmaceuticals
Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VRTX
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.
VRTX Key Statistics
Stock Snapshot
The current Vertex Pharmaceuticals(VRTX) stock price is $514.63, with a market capitalization of 130.46B. The stock trades at a price-to-earnings (P/E) ratio of 30.22.
On 2026-09-15, Vertex Pharmaceuticals(VRTX) stock moved within a range of $511.00 to $519.94. With shares now at $514.63, the stock is trading +0.7% above its intraday low and -1.0% below the session's peak.
Trading activity shows a volume of 792.97K, compared to an average daily volume of 950.72K.
The stock's 52-week range extends from a low of $374.17 to a high of $560.25.
The stock's 52-week range extends from a low of $374.17 to a high of $560.25.
VRTX News
...
Vertex Pharmaceuticals recently outlined progress in its renal and rare endocrine pipeline, including an FDA decision expected in November for povetacicept in I...
Vertex Pharmaceuticals (VRTX) has partnered with world champion skier Lindsey Vonn to raise awareness of JOURNAVX, a prescription non-opioid medicine for the tr...
Analyst ratings
76%
of 34 ratingsMore VRTX News
Vertex Pharmaceuticals (NASDAQ:VRTX) is continuing to broaden its business beyond cystic fibrosis, with its renal medicine portfolio, rare endocrine assets and...
Key Points Amgen maintains a massive, diversified portfolio of medicines serving approximately 17 million patients globally. Vertex Pharmaceuticals dominates...
Vertex Pharmaceuticals (NASDAQ:VRTX) highlighted a series of upcoming clinical, regulatory and commercial catalysts across renal disease, pain management, cysti...
Vertex Pharmaceuticals (NASDAQ:VRTX) outlined a broadening commercial and clinical strategy at the Cantor Global Healthcare Conference, highlighting its recent...
JPMorgan reinstated coverage of Vertex Pharmaceuticals (VRTX) with an Overweight rating and price target of $560, up from $515, following a period of restrictio...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.